Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · IEX Real-Time Price · USD

14.18

-0.11 (-0.77%)

Nov 27, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018
Revenue	9.69	7.57	41.82	57.05	0
Revenue Growth (YoY)	27.91%	-81.89%	-26.70%	-	-
Gross Profit	9.69	7.57	41.82	57.05	0
Selling, General & Admin	39.95	27.56	17.27	10.93	6.5
Research & Development	96.94	77.55	66.19	47.35	24.42
Operating Expenses	136.89	105.11	83.46	58.28	30.92
Operating Income	-127.2	-97.54	-41.65	-1.23	-30.92
Interest Expense / Income	0.79	0	0	0	0
Other Expense / Income	-4.67	-0.27	-0.11	-0.6	-0.64
Pretax Income	-123.32	-97.26	-41.53	-0.63	-30.28
Net Income	-123.32	-97.26	-41.53	-0.63	-30.28
Preferred Dividends	0	0	0	6.23	4.88
Net Income Common	-123.32	-97.26	-41.53	-6.86	-35.15
Shares Outstanding (Basic)	42	36	21	2	1
Shares Outstanding (Diluted)	42	36	21	2	1
Shares Change	17.21%	67.94%	1214.82%	39.29%	-
EPS (Basic)	-2.94	-2.71	-1.95	-4.22	-30.16
EPS (Diluted)	-2.94	-2.71	-1.95	-4.22	-30.16
Free Cash Flow	-96.39	-77.4	-38.8	-3.71	-30.65
Free Cash Flow Per Share	-2.29	-2.16	-1.82	-2.29	-26.30
Gross Margin	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-1313.37%	-1288.10%	-99.59%	-2.16%	-
Profit Margin	-1273.32%	-1284.51%	-99.32%	-12.02%	-
Free Cash Flow Margin	-995.26%	-1022.13%	-92.79%	-6.51%	-
EBITDA	-118.85	-94.06	-40.22	0.48	-29.61
EBITDA Margin	-1227.15%	-1242.19%	-96.19%	0.84%	-
Depreciation & Amortization	3.68	3.2	1.31	1.11	0.67
EBIT	-122.53	-97.26	-41.53	-0.63	-30.28
EBIT Margin	-1265.15%	-1284.51%	-99.32%	-1.11%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).